Ragon Institute of Mass General, MIT, and Harvard
Justine Alexander is a skilled research technologist currently working at the Ragon Institute of Mass General, MIT, and Harvard since June 2023, focusing on molecular cloning and antibody expression/testing. Previously, Justine served as a Senior Research Associate at Cytovia Therapeutics, where responsibilities included molecular cloning, gene editing, and various assays. Justine's prior experience also encompasses research roles at UMass Chan Medical School, Heat Biologics, Memorial Sloan Kettering Cancer Center, and the University of Oklahoma Health Sciences Center, accumulating expertise in techniques such as flow cytometry, PCR, and drug engineering. Justine holds a Bachelor of Science in Microbiology from the University of Oklahoma and completed graduate studies at Penn State University.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.